Member Info for stu485

HH,

I don’t think they’ll consider Kings alleged VS private mail as sharing insider information , i’m not 100% sure ?

Although you did confirm to all it was genuine. So maybe they will .

AIMO

D68,

Good point.

HT,

I know it’s still very tender and it’s clear some of the posts today making it itch, but don’t scratch, it’ll just make it much worse.

I’m looking forward to more of Vlad’s words and less of yours.

Bring on the RNS Vlad !

AIMO

Mr I’s

Hallelujah to that !

All down to VS .

AIMO

FG,

It’s a start, we just now need to know;

- why the confidence and how soon?

I see no reason why we won’t receive that important news before the AGM.

Over to VS.

AIMO

Mr I,

Unfortunately for you, most now understand your true identities and motives and pay little attention to your rambling ramping, if they ever did.

The only reason for the poor SP performance is the company failure to gain IND clearance and lack of clarity on confidence and timeline to FDA Complete Response.

If you believe it to be for any other reason then you’re both more foolish than i thought you were.

The company can address the problem even if they’re not yet in receipt of the FDA deficiencies letter, odds are they are anyway.

I’m afraid it’s out of our hands, …all three of us!

Over to VS ?

AIMO

As previous ,

i hope for a shareholder reassuring RNS reach lands early in the week. We know the company can deliver it if they wish.

Just simply outline the probable time line for their complete response to the FDA and reasons for confidence.

Without the above before the AGM, I’d anticipate the start of another slide in SP.

Fingers crossed for that RNS.

AIMO

King1,

I’m neither rude or ignorant.

To suggest so would be rude and ignorant !

Why did your VS ramp email get taken down ?

Why didn’t you check your fantasy Mcap ramp numbers with HK before he completely contradicted you ?

Must still be tender then.

Have a good evening.

King,

Would you mind using the attached industry best practice calculator to make your Mcap estimate something we could then consider as worthy of consideration.

https://www.toptal.com/finance/valuation/biotech-valuation

AIMO

Ps I note your VS post had been removed, why ?

Mickey,

Unfortunately the only time limit to response is 1year from issue of CH. At that point in the absence of a Complete Response by the sponsor (Hemo’),the IND is suspended.

That’s the reason so many bailed out, particularly as the company would not offer any timeline on their intended complete response!

No timeline!!

AIMO

“If even higher doses of AVA6000 are tolerated then this may make a significant difference to the outcomes for patients in the upcoming efficacy study. “

This the only info’ you need to consider within RNS.

Have a deep think on it !?

AIMO

Wynd,

Thanks for the insight.

Wynd,

100% correct regarding the use and implications of the word "imminent"

Unfortunately many on LSE struggle to interpret simple communications.

Anyway, I'm looking to enter but my concerns more with the word "Anticipate".

Anticipate strong news flow ?... translates to me, "we think there'll be strong news flow".

A bit wishy-washy wording if they were VERY confident don't you think?

AIMO

Mr I,

There’s no hypocrisy or inconsistency within my posts!

If there’s any confusion that would only be due to lack of understanding .

The only thing we agree on is proper positive news is needed urgently and i expect it will come before the AGM.

I’m signing off until then.

GLA

AIMO

Mr I,

We all know you’re desperate but spare a thought for newbie’s please with your “optimistic” projections.

Until news, either before or at the AGM this will just be traded up and down a little.

Although i must confess, looking at some of the earlier reasonable buys and considering the spread at the time,

I suspect HT has sold a kidney!

AIMO

…Hemo’ not GSK

The FDA clinical hold is presently not about backlog or being snowed under, we know this as a fact !

The future fortunes of the SP and possibly even the company as a whole boils down to an urgent market reassuring RNS reach release, simply outlining reasons for their stated Car-T confidence.

The company IS in a position to do this, also a fact!

So, In the unlikely event they choose no to, it’s only for one of two reasons.

1,They are uninterested in market perception.

2,They have a serious problem in timely attendance to the FDA concerns.

The first very bad, the second possibly terminal !

I’m anticipating a positive RNS reach this month.

GLA

AIMO

Chris,

I’ve heard nothing.

I’m simply trying to consider what i’d do in the companies current position and understanding the various bits of information we do have.

As to “imminent” , probably the wrong word in the strictest sense of the meaning but very glad some on this board are starting to scrutinize every word, particularly important come RNS time.

I suspect within a couple of weeks if they are to put out a market reassuring RNS reach.

I’ve bought some more stock today because i can see no reason why they now wouldn’t do especially with their benefit of hindsight on prior RNS.

It’s simply coincidence that my timeframe of “imminent” is similar to that the company has used previously both wrong!

AIMO

Mr I,

Unlike you and the ramp gang, you’ll notice i went out of my way to state i could be completely wrong as unlike you i’m not trying to encourage others to buy in.

If I’m correct the rise will be reflective of the confidence and detail the company can offer within such an RNS reach.

Give me their RNS reach writing pencil and it could easily be back up over 2p.

AIMO

Mr I,

Why would you ask me when I’m untrustworthy?